Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Advanced Proteome Therapeutics’ Lead Compound Inhibits Metastasis in Breast Cancer Tumor Model

VANCOUVER, BC–(Marketwired – April 29, 2015) – Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce that its current lead compound APC 101 successfully diminished the frequency of tumor metastasis in the 4T1 animal model. The Company’s academic collaborators used three different methods, carried out over several […]

Read More »

Amgen Announces FDA Advisory Committee Meeting To Review Repatha (Evolocumab) As A Treatment For High Cholesterol

THOUSAND OAKS, Calif., April 29, 2015 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S. Food and Drug Administration (FDA) will review data supporting the Company’s Biologics License Application (BLA) for RepathaTM (evolocumab) for the treatment of high cholesterol at a meeting on June 10, 2015. Repatha […]

Read More »

Philips launches innovative 3D navigation system to enhance minimally invasive treatment of vascular disease

• VesselNavigator has been designed for use in conjunction with Philips interventional X-ray systems to guide catheters during treatment of vascular disease. • Major reduction of contrast medium (70%) demonstrated in clinical study, enabling minimally invasive treatment of aortic aneurysms in the fast growing number of patients currently unable to benefit from minimally-invasive techniques. Amsterdam, […]

Read More »

Alexza Pharmaceuticals Announces Management Promotions

MOUNTAIN VIEW, Calif., April 29, 2015 /PRNewswire/ — Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced two management promotions.  Dr. Edwin S. Kamemoto has been promoted to the newly created position of Executive Vice President, R&D and Quality.  In this new role,  Dr. Kamemoto will be responsible for research and development, regulatory affairs, clinical research, pharmacovigilance, and the […]

Read More »

No Benefit For A Commonly Used Cardiac Device

Once again, after decades of common use, a frequently implanted device has been found to confer no benefit whatsoever over a much less invasive therapy. Cardiologists and radiologists often implant the device, called a retrievable inferior vena cava filter, inside people who are at high risk for developing potentially lethal blood clots. The filter is designed to prevent […]

Read More »

BIO Praises the Release of 21st Century Cures Initiative Discussion Draft

WASHINGTON–(BUSINESS WIRE)–The Biotechnology Industry Organization (BIO) today releases the following statement on the 21st Century Cures Initiative discussion draft shared by Chairman Fred Upton (R-MI), Rep. Diana DeGette (D-CO), Rep. Frank Pallone, Jr. (D-NJ), Rep. Joe Pitts (R-PA), and Rep. Gene Green (D-TX). This statement can be attributed to Jim Greenwood, BIO President and CEO: […]

Read More »

Kids of severely obese moms have higher risk of ADHD

File photo of a woman with a child on the beach in Santa Monica, California, May 12, 2012. Reuters/David McNew (This version of the story was refiled to correct name of the researcher interviewed for this story, from Heejoo Jo to Laura Schieve; Replaces para 2; fixes paras 3, 5, 10, 13, 15, and 17.) […]

Read More »

Are Nanoparticles the New Secret Weapon Against Tooth Decay?

LOS ANGELES, April 29, 2015 /PRNewswire/ — Technological innovation and scientific discovery are critical components of healthcare that have greatly improved treatment and patient care across all fields of medicine. As medical experts and scientists continue to find new and better ways to prevent and cure maladies, patients continue to benefit from practices that are increasingly […]

Read More »

Betting On China For New Drug Development

Healthcare investment firm OrbiMed manages over $14 billion in public and private equity, nearly $1.4 billion of which is focused on Asia. With 23 private equity investments in Asia, OrbiMed is spreading its interests across the healthcare spectrum, including drugs, medical devices, services and enabling technology. Jonathan Wang, senior managing director at OrbiMed, joined the […]

Read More »

Eating sugar may fuel cravings for more by quieting stress

(Reuters Health) – Eating sugar may quiet stress signals in the brain, leading some people to seek comfort by consuming more sweets and making the habit very hard to break, a small study suggests. In a two-week experiment, 19 women drank three beverages a day sweetened either with real sugar or aspartame, a substitute. Researchers […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom